Efrat Flashner-Abramson

518 total citations
13 papers, 393 citations indexed

About

Efrat Flashner-Abramson is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Efrat Flashner-Abramson has authored 13 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Efrat Flashner-Abramson's work include Bioinformatics and Genomic Networks (6 papers), Computational Drug Discovery Methods (3 papers) and Immunotherapy and Immune Responses (2 papers). Efrat Flashner-Abramson is often cited by papers focused on Bioinformatics and Genomic Networks (6 papers), Computational Drug Discovery Methods (3 papers) and Immunotherapy and Immune Responses (2 papers). Efrat Flashner-Abramson collaborates with scholars based in Israel, United States and Australia. Efrat Flashner-Abramson's co-authors include Alexander Levitzki, Shabnam Shalapour, Zhenyu Zhong, Koji Taniguchi, Elsa Sánchez‐López, Michael Karin, Alexei Shir, Menashe Bar‐Eli, Nataly Kravchenko‐Balasha and Hadas Reuveni and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Oncogene.

In The Last Decade

Efrat Flashner-Abramson

13 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Efrat Flashner-Abramson Israel	10	230	150	97	73	46	13	393
Shweta Kotian United States	9	336 1.5×	110 0.7×	88 0.9×	36 0.5×	20 0.4×	10	420
Trace S. Tsuruda United States	7	199 0.9×	104 0.7×	44 0.5×	44 0.6×	24 0.5×	8	403
María C. Díaz Flaqué Argentina	14	299 1.3×	314 2.1×	108 1.1×	86 1.2×	90 2.0×	23	627
Luigi Alfano Italy	11	271 1.2×	95 0.6×	45 0.5×	36 0.5×	18 0.4×	23	396
Takao Yamori Japan	6	208 0.9×	220 1.5×	88 0.9×	79 1.1×	47 1.0×	8	405
Masumi Yoshie Japan	8	191 0.8×	135 0.9×	108 1.1×	48 0.7×	12 0.3×	15	392
M. Anthony Leesnitzer United States	10	288 1.3×	179 1.2×	122 1.3×	33 0.5×	46 1.0×	11	536
Charlotte Andrieu France	8	207 0.9×	178 1.2×	154 1.6×	22 0.3×	19 0.4×	12	441
Carmen E. Pyragius Australia	10	248 1.1×	84 0.6×	121 1.2×	54 0.7×	19 0.4×	10	393
Yabing Zheng China	14	278 1.2×	97 0.6×	124 1.3×	105 1.4×	9 0.2×	20	477

Countries citing papers authored by Efrat Flashner-Abramson

Since Specialization

Citations

This map shows the geographic impact of Efrat Flashner-Abramson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Efrat Flashner-Abramson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Efrat Flashner-Abramson more than expected).

Fields of papers citing papers by Efrat Flashner-Abramson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Efrat Flashner-Abramson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Efrat Flashner-Abramson. The network helps show where Efrat Flashner-Abramson may publish in the future.

Co-authorship network of co-authors of Efrat Flashner-Abramson

This figure shows the co-authorship network connecting the top 25 collaborators of Efrat Flashner-Abramson. A scholar is included among the top collaborators of Efrat Flashner-Abramson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Efrat Flashner-Abramson. Efrat Flashner-Abramson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Flashner-Abramson, Efrat, et al.. (2022). Overcoming resistance to EGFR monotherapy in HNSCC by identification and inhibition of individualized cancer processes. Theranostics. 12(3). 1204–1219. 11 indexed citations

Rubinstein, Ariel M., Efrat Flashner-Abramson, Zvi Granot, et al.. (2022). Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance. Genome Medicine. 14(1). 120–120. 14 indexed citations

Flashner-Abramson, Efrat, et al.. (2021). Overcoming resistance to BRAFV600E inhibition in melanoma by deciphering and targeting personalized protein network alterations. npj Precision Oncology. 5(1). 50–50. 17 indexed citations

Flashner-Abramson, Efrat, et al.. (2020). Exploring Alzheimer’s Disease Molecular Variability via Calculation of Personalized Transcriptional Signatures. Biomolecules. 10(4). 503–503. 5 indexed citations

Flashner-Abramson, Efrat, et al.. (2019). Decoding cancer heterogeneity: studying patient-specific signaling signatures towards personalized cancer therapy. Theranostics. 9(18). 5149–5165. 29 indexed citations

Su, Shih‐Ping, Efrat Flashner-Abramson, Shoshana Klein, et al.. (2018). Impact of the Anticancer Drug NT157 on Tyrosine Kinase Signaling Networks. Molecular Cancer Therapeutics. 17(5). 931–942. 14 indexed citations

Flashner-Abramson, Efrat, Jonathan J. Abramson, Forest M. White, & Nataly Kravchenko‐Balasha. (2018). A thermodynamic-based approach for the resolution and prediction of protein network structures. Chemical Physics. 514. 20–30. 7 indexed citations

Flashner-Abramson, Efrat, et al.. (2018). Personalized disease signatures through information-theoretic compaction of big cancer data. Proceedings of the National Academy of Sciences. 115(30). 7694–7699. 14 indexed citations

Shir, Alexei, et al.. (2017). PSMA-targeted polyinosine/polycytosine vector induces prostate tumor regression and invokes an antitumor immune response in mice. Proceedings of the National Academy of Sciences. 114(52). 13655–13660. 10 indexed citations

10.

Flashner-Abramson, Efrat, Naomi Melamed‐Book, Mario Lebendiker, et al.. (2017). PSMA-homing dsRNA chimeric protein vector kills prostate cancer cells and activates anti-tumor bystander responses. Oncotarget. 8(15). 24046–24062. 5 indexed citations

11.

Sánchez‐López, Elsa, Efrat Flashner-Abramson, Shabnam Shalapour, et al.. (2015). Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling. Oncogene. 35(20). 2634–2644. 131 indexed citations

12.

Flashner-Abramson, Efrat, Shiri Klein, Gerard E. Mullin, et al.. (2015). Targeting melanoma with NT157 by blocking Stat3 and IGF1R signaling. Oncogene. 35(20). 2675–2680. 35 indexed citations

13.

Reuveni, Hadas, Efrat Flashner-Abramson, Lilach Steiner, et al.. (2013). Therapeutic Destruction of Insulin Receptor Substrates for Cancer Treatment. Cancer Research. 73(14). 4383–4394. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact